Skip header and navigation

Refine By

101 records – page 1 of 11.

Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population-based case-control study.

https://arctichealth.org/en/permalink/ahliterature26647
Source
Cancer. 1985 Feb 1;55(3):643-7
Publication Type
Article
Date
Feb-1-1985
Author
H O Adami
R. Bergström
J. Hansen
Source
Cancer. 1985 Feb 1;55(3):643-7
Date
Feb-1-1985
Language
English
Publication Type
Article
Keywords
Adult
Aged
Aging
Breast Neoplasms - epidemiology - pathology
Epidemiologic Methods
Female
Humans
Middle Aged
Neoplasms, Multiple Primary - epidemiology - pathology
Research Support, Non-U.S. Gov't
Risk
Sweden
Abstract
This epidemiologic investigation comprised 1351 of 1423 women in a defined geographic area consecutively diagnosed as having a primary breast cancer. Simultaneous bilateral disease occurred in only 1 patient, whereas a history of previous cancer in the contralateral breast was reported by 65 patients. This prevalence was related to that of 23 previous cases in an age-matched control group of 1351 women from the same population. The relative risk of developing a second primary was 2.9 (95% confidence limit, 1.8-4.6) for the whole material and remained seemingly constant over several decades at a level predetermined by age at first diagnosis, namely 9.9 (95% confidence limit, 3.8-25.8) before the age of 50 and 1.9 (95% confidence limit, 1.1-3.2) after that age. The incidence ratio of bilateral to unilateral disease was used as an estimate of the lifetime risk of developing a second primary in this stable and well-defined population. This calculation revealed cumulative risk figures of 13.3% and 3.5% for women younger and older than 50 years, respectively, at first diagnosis. It was concluded that the occurrence of bilateral disease, which reflects a multicentric neoplastic transformation of the breast epithelium, is a characteristic of early-occurring (premenopausal) disease.
PubMed ID
3965112 View in PubMed
Less detail

Agreement between hopelessness/helplessness and Montgomery-Asberg Depression Rating Scale in healthy individuals and in patients with benign breast disease and breast cancer: a prospective case-control study in Finland.

https://arctichealth.org/en/permalink/ahliterature266661
Source
Anticancer Res. 2015 Apr;35(4):2215-21
Publication Type
Article
Date
Apr-2015
Author
Matti Eskelinen
Riika Korhonen
Tuomas Selander
Paula Ollonen
Source
Anticancer Res. 2015 Apr;35(4):2215-21
Date
Apr-2015
Language
English
Publication Type
Article
Keywords
Adult
Breast - pathology
Breast Neoplasms - epidemiology - pathology - psychology
Case-Control Studies
Depression - epidemiology - pathology - psychology
Female
Finland
Humans
Middle Aged
Prognosis
Questionnaires
Abstract
The relation between scoring for hopelessness/helplessness and the Montgomery-Asberg Depression Rating Scale (MADRS) in healthy study subjects (HSS) and in patients with benign breast disease (BBD) and breast cancer (BC) has not been compared in a prospective study. We, therefore, investigated hopelessness and helplessness scores versus the MADRS in 115 patients.
In the Kuopio Breast Cancer Study, 115 women with breast symptoms were evaluated for hopelessness and helplessness, and for the MADRS before any diagnostic procedures were carried out.
In the self-rating score (SRS), hopelessness/helplessness versus the MADRS were highly significantly positively correlated in the HSS, BBD and BC groups. In the SRS, the weighted kappa values for hopelessness/helplessness versus the MADRS in the HSS, BBD and BC groups were also statistically significant. There was also a significant positive correlation in the examiner-rating score (ERS) for hopelessness versus the MADRS in the HSS, BBD and BC groups and for helplessness versus the MADRS in the HSS, BBD and BC groups. The unweighted kappa values in the ERS for hopelessness versus the MADRS were statistically highly significant for the HSS, BBD and BC groups and those for helplessness versus the MADRS in the HSS and BBD groups were statistically significant.
A new finding with clinical relevance in the present work is the agreement between hopelessness/helplessness scores and MADRS in the SRS and ERS. In the breast cancer diagnostic unit, the identification of hopeless/helpless persons is essential in suicide prevention and it is important to assess and treat hopelessness/helplessness even though an individual may report few depressive symptoms.
PubMed ID
25862881 View in PubMed
Less detail

Alcohol consumption and risk of benign proliferative epithelial disorders of the breast: a case-cohort study.

https://arctichealth.org/en/permalink/ahliterature197612
Source
Public Health Nutr. 1998 Sep;1(3):139-45
Publication Type
Article
Date
Sep-1998
Author
T E Rohan
M. Jain
A B Miller
Author Affiliation
Department of Public Health Sciences, University of Toronto, Canada. tom.rohan@utoronto.ca
Source
Public Health Nutr. 1998 Sep;1(3):139-45
Date
Sep-1998
Language
English
Publication Type
Article
Keywords
Adult
Alcohol Drinking - adverse effects - epidemiology
Breast Neoplasms - epidemiology - pathology
Canada - epidemiology
Case-Control Studies
Cohort Studies
Diet Surveys
Female
Fibrocystic Breast Disease - epidemiology - etiology - pathology
Humans
Incidence
Middle Aged
Precancerous Conditions - epidemiology - pathology
Questionnaires
Registries
Risk factors
Abstract
To study the association between alcohol consumption and risk of benign proliferative epithelial disorders (BPED) of the breast (conditions which are thought to have premalignant potential).
Case-cohort study.
The study was undertaken within the 56,537 women in the Canadian National Breast Screening Study (NBSS) who completed self-administered dietary questionnaires. (The NBSS is a randomized controlled trial of screening for breast cancer in women aged 40-59 years at recruitment.)
The study subjects were the 657 women in the dietary cohort who were diagnosed with biopsy-confirmed incident BPED. For comparative purposes, a subcohort consisting of a random sample of 5681 women was selected from the full dietary cohort. After exclusions for various reasons, the analyses were based on 557 cases and 5028 non-cases.
When compared to non-drinkers, rate ratios (95% CI) for those consuming > 0 and 10 and 20 and 30 g day(-1) were 0.35 (0.27-0.45), 0.26 (0.18-0.39), 0.29 (0.18-0.48), and 0.23 (0.13-0.40), respectively (the associated P value for the trend was 0.089). Similar findings were obtained from analyses conducted separately in the screened and control arms of the NBSS, in premenopausal and postmenopausal women, and for non-atypical and atypical forms of BPED, and there was little difference between the results for screen-detected and interval-detected BPED.
Alcohol consumption was associated with a non-dose-dependent reduction in risk of BPED.
PubMed ID
10933411 View in PubMed
Less detail

Association of symptoms and breast cancer in population-based mammography screening in Finland.

https://arctichealth.org/en/permalink/ahliterature262140
Source
Int J Cancer. 2015 Mar 15;136(6):E630-7
Publication Type
Article
Date
Mar-15-2015
Author
Deependra Singh
Nea Malila
Arun Pokhrel
Ahti Anttila
Source
Int J Cancer. 2015 Mar 15;136(6):E630-7
Date
Mar-15-2015
Language
English
Publication Type
Article
Keywords
Age Factors
Aged
Breast Neoplasms - epidemiology - pathology - radiography
Early Detection of Cancer
Female
Finland - epidemiology
Humans
Mammography
Middle Aged
Abstract
The study purpose was to assess association of symptoms at screening visits with detection of breast cancer among women aged 50-69 years during the period 2006-2010. Altogether 1.2 million screening visits were made and symptoms (lump, retraction, secretion etc.) were reported either by women or radiographer. Breast cancer risk was calculated for each symptom separately using logistic regression [odds ratio (OR)] and 95% confidence intervals (CIs). Of the 1,198,410 screening visits symptoms were reported in 298,220 (25%) visits. Breast cancer detection rate for women with and without symptoms was 7.8 per 1,000 and 4.7 per 1,000 screening visits, respectively, whereas lump detected 32 cancers per 1,000 screens. Women with lump or retraction had an increased risk of breast cancer, OR?=?6.47, 95% CI 5.89-7.09 and OR?=?2.19, 95% CI 1.92-2.49, respectively. The sensitivity of symptoms in detecting breast carcinoma was 35.5% overall. Individual symptoms sensitivity and specificity ranged from, 0.66 to 14.8% and 87.4 to 99.7%, respectively. Of 5,541 invasive breast cancers, 1,993 (36%) reported symptoms at screen. Breast cancer risk among women with lump or retraction was higher in large size tumors (OR?=?9.20, 95% CI 8.08-10.5) with poorly differentiated grades (OR?=?5.91, 95% CI 5.03-6.94) and regional lymph nodes involvement (OR?=?6.47, 95% CI 5.67-7.38). This study was done in a setting where breast tumors size is generally small, and symptoms sensitivity and specificity in diagnosing breast tumors were limited. Importance of breast cancer symptoms in the cancer prevention and control strategy needs to be evaluated also in other settings.
Notes
Cites: Int J Cancer. 2008 Feb 1;122(3):614-917847022
Cites: J Am Board Fam Pract. 2004 Nov-Dec;17(6):408-1515575032
Cites: J Natl Cancer Inst. 2011 Oct 5;103(19):1476-8021862730
Cites: Breast Cancer Res Treat. 2012 Jan;131(2):527-4022042364
Cites: J Med Screen. 2012;19 Suppl 1:33-4122972809
Cites: BMC Cancer. 2012;12:60423244222
Cites: BMJ. 2014;348:g36624519768
Cites: Stat Med. 1998 Apr 30;17(8):857-729595616
Cites: Am Fam Physician. 2000 Apr 15;61(8):2371-8, 238510794579
Cites: J Natl Cancer Inst. 2000 Jun 21;92(12):971-610861308
Cites: Radiology. 2002 Feb;222(2):536-4211818625
Cites: Biomed Pharmacother. 2002 Mar;56(2):88-9212000140
Cites: J Natl Cancer Inst. 2002 Aug 7;94(15):1151-912165640
Cites: Clin Radiol. 2002 Aug;57(8):725-912169283
Cites: AJR Am J Roentgenol. 2003 May;180(5):1461-712704069
Cites: Jpn J Cancer Res. 1989 Nov;80(11):1028-342514163
Cites: J Clin Epidemiol. 1991;44(8):763-701941027
Cites: Can J Surg. 1992 Feb;35(1):41-51739898
Cites: Am Surg. 1992 Jul;58(7):413-71616186
Cites: JAMA. 1996 Jul 3;276(1):33-88667536
Cites: Am J Surg. 1997 Mar;173(3):181-49124622
Cites: J Natl Cancer Inst Monogr. 2005;(35):67-7116287888
Cites: Br J Cancer. 2005 Jan 17;92(1):156-6115597100
Cites: Br J Cancer. 2009 Oct 20;101(8):1338-4419773756
PubMed ID
25160029 View in PubMed
Less detail

Autopsy studies of the occurrence of cancerous, atypical and benign epithelial lesions in the female breast.

https://arctichealth.org/en/permalink/ahliterature25658
Source
APMIS Suppl. 1989;10:1-56
Publication Type
Article
Date
1989
Author
M. Nielsen
Source
APMIS Suppl. 1989;10:1-56
Date
1989
Language
English
Publication Type
Article
Keywords
Autopsy
Breast Diseases - pathology - radiography
Breast Neoplasms - epidemiology - pathology - radiography
Epithelium - pathology
Female
Humans
Lymphatic Metastasis
Prognosis
Research Support, Non-U.S. Gov't
Risk factors
Abstract
The main purpose of the present thesis has been to estimate the frequency of malignant, premalignant and benign morphological changes in the female breast and evaluate their possible interrelationship. The method used was a conventional but detailed and systematic examination, both macroscopically and histologically of all available breast tissue. Consequently autopsi material has been the natural basis of the studies. Three groups of women have been examined: 1. A consecutive series of 110 younger women, mean age 39 years, undergoing medicolegal autopsy at the Institute of Forensic Medicine in Copenhagen, Denmark, from October 1983 to July 1984. 2. A consecutive series of 83 unselected, elderly women, mean age 67 years, undergoing autopsy at a large community hospital in Esbjerg, Jutland, Denmark, from November 1976 to May 1977. 3. A consecutive series of 84 women, mean age 74 years, dying with a known diagnosis of breast cancer and undergoing autopsy at two community hospitals in the Copenhagen area, (Glostrup and Frederiksberg), Denmark, from November 1982 to December 1984. The main results were: 1. In younger women clinically occult in situ breast cancer lesions occurred with surprisingly high frequency, 18%, a result which may influence the planning of future screening programs. 2. In elderly women, dying from a number of various reasons, invasive breast carcinomas were found with a frequency corresponding to the life-long risk of Danish women having this disease diagnosed clinically, 8%. Occult in situ carcinomas were found in 18%. 3. In women dying with a clinical diagnosis of breast cancer, the frequency of malignant histological changes in the opposite breast (metastases, invasive and in situ breast carcinomas) was unexpectedly high, 80%, a result which should be taken into consideration during clinical follow-up after treatment for breast cancer.
PubMed ID
2692656 View in PubMed
Less detail

Axillary lymph node biopsy in newly diagnosed invasive breast cancer: comparative accuracy of fine-needle aspiration biopsy versus core-needle biopsy.

https://arctichealth.org/en/permalink/ahliterature113023
Source
Radiology. 2013 Oct;269(1):54-60
Publication Type
Article
Date
Oct-2013
Author
Suvi Rautiainen
Amro Masarwah
Mazen Sudah
Anna Sutela
Outi Pelkonen
Sarianna Joukainen
Reijo Sironen
Vesa Kärjä
Ritva Vanninen
Author Affiliation
Departments of Clinical Radiology, Surgery, and Clinical Pathology, Kuopio University Hospital, PO Box 1777, Puijonlaaksontie 2, 70210 Kuopio, Finland; Units of Radiology and Pathology and Forensic Medicine at Institute of Clinical Medicine, Biocenter Kuopio, and Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
Source
Radiology. 2013 Oct;269(1):54-60
Date
Oct-2013
Language
English
Publication Type
Article
Keywords
Adult
Aged
Aged, 80 and over
Axilla - pathology
Biopsy, Fine-Needle - statistics & numerical data
Biopsy, Large-Core Needle - statistics & numerical data
Breast Neoplasms - epidemiology - pathology
Female
Finland - epidemiology
Humans
Image-Guided Biopsy - statistics & numerical data
Lymph Nodes - pathology
Lymphatic Metastasis
Middle Aged
Neoplasm Invasiveness
Prevalence
Reproducibility of Results
Sensitivity and specificity
Ultrasonography, Mammary - statistics & numerical data
Abstract
To compare the diagnostic accuracy of ultrasonographically (US)-guided fine-needle aspiration biopsy (FNAB) and core-needle biopsy (CNB) of the axillary lymph nodes (LNs) of patients with newly diagnosed invasive breast cancer.
This prospective single-center study had institutional review board approval, and written informed consent was obtained. Between April 2011 and March 2012, 178 consecutive patients (182 axillae) were evaluated by using axillary US. Sixty-six axillae fulfilled the inclusion criteria (cortical thickness greater than 2 mm or abnormal morphologic characteristics), and patients with these axillae underwent US-guided axillary LN biopsy. Both FNAB and CNB were obtained from the same suspicious LN. Patients with biopsy-proved metastasis underwent axillary clearance, and those with a negative biopsy underwent sentinel LN biopsy with completion axillary clearance if needed. Diagnostic performance was calculated separately for US, FNAB, and CNB. Statistical differences in sensitivities were evaluated by using the McNemar test.
From the total study population, 45.6% (83 of 182 axillae) had metastases. A total of 66 axillae underwent both FNAB and CNB. The sensitivity for US was 61.4% (51 of 83 axillae), and specificity was 84.8% (84 of 88 axillae). The sensitivities for FNAB and CNB were 72.5% (37 of 51 axillae) and 88.2% (45 of 51 axillae), respectively (P = .008). Specificity for both was 100% (15 of 15 axillae). The negative predictive value for FNAB was 81.7%, and that for CNB was 91.2%. The positive predictive value was 100% for both methods.
When accurate preoperative staging of the axilla is needed in patients with newly diagnosed invasive breast cancer, CNB is more sensitive than FNAB.
PubMed ID
23771915 View in PubMed
Less detail

Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish Multicenter Cohort Study.

https://arctichealth.org/en/permalink/ahliterature87504
Source
Ann Surg. 2008 Jan;247(1):150-6
Publication Type
Article
Date
Jan-2008
Author
Bergkvist Leif
de Boniface Jana
Jönsson Per-Ebbe
Ingvar Christian
Liljegren Göran
Frisell Jan
Author Affiliation
Department of Surgery and Center for Clinical Research, Uppsala University, Central Hospital, Västerås, Sweden.
Source
Ann Surg. 2008 Jan;247(1):150-6
Date
Jan-2008
Language
English
Publication Type
Article
Keywords
Adult
Aged
Aged, 80 and over
Axilla
Breast Neoplasms - epidemiology - pathology
Female
Follow-Up Studies
Humans
Incidence
Lymphatic Metastasis
Middle Aged
Neoplasm Recurrence, Local - epidemiology
Prospective Studies
Risk factors
Sentinel Lymph Node Biopsy
Survival Analysis
Sweden - epidemiology
Abstract
BACKGROUND: Sentinel lymph node biopsy is an established staging method in early breast cancer. After a negative biopsy, most institutions will not perform a completion axillary dissection. The present study reports the current axillary recurrence (AR) rate, overall and disease-free survival in the Swedish Multicenter Cohort Study. METHODS: From 3534 patients with primary breast cancer
PubMed ID
18156935 View in PubMed
Less detail

Baseline patterns of adipose tissue fatty acids and long-term risk of breast cancer: a case-cohort study in the Danish cohort Diet, Cancer and Health.

https://arctichealth.org/en/permalink/ahliterature264936
Source
Eur J Clin Nutr. 2014 Oct;68(10):1088-94
Publication Type
Article
Date
Oct-2014
Author
J A Schmidt
A. Gorst-Rasmussen
P W Nyström
J H Christensen
E B Schmidt
C. Dethlefsen
A. Tjønneland
K. Overvad
C C Dahm
Source
Eur J Clin Nutr. 2014 Oct;68(10):1088-94
Date
Oct-2014
Language
English
Publication Type
Article
Keywords
Adult
Aged
Breast Neoplasms - epidemiology - pathology
Cohort Studies
Denmark - epidemiology
Fatty Acids - analysis
Female
Humans
Incidence
Male
Middle Aged
Prospective Studies
Risk
Risk factors
Subcutaneous Fat - chemistry
Abstract
The evidence regarding fatty acids and breast cancer risk is inconclusive. Adipose tissue fatty acids can be used as biomarkers of fatty acid intake and of endogenous fatty acid exposure. Fatty acids in adipose tissue are correlated owing to common dietary sources and shared metabolic pathways, which group fatty acids into naturally occurring patterns. We aimed to prospectively investigate associations between adipose tissue fatty acid patterns and long-term risk of total breast cancer and breast cancer subtypes characterised by oestrogen and progesterone receptor status (ER and PR).
This case-cohort study was based on data from the Danish cohort Diet, Cancer and Health. At baseline, a fat biopsy and information on lifestyle and reproductive factors were collected. From the 31 original fatty acids measured, patterns of fatty acids were identified using the treelet transform. During a median follow-up of 5.3 years, 474 breast cancer cases were identified. Hazard ratios and 95% confidence intervals of risk of total breast cancer and of subtypes according to quintiles of factor score were determined by weighted Cox proportional hazards regression.
After adjustment for potential confounders, factor scores for the seven patterns identified by the treelet transform were not associated with risk of total breast cancer, nor with risk of ER+, ER-, PR+ or PR- tumours.
No clear associations between the patterns of fatty acids at baseline and long-term risk of total breast cancer or ER+, ER-, PR+ or PR- tumours were observed.
PubMed ID
24642780 View in PubMed
Less detail

Breast cancer and clinical outcome among women over 60 years of age: a plead for more screening and alternative treatments.

https://arctichealth.org/en/permalink/ahliterature120327
Source
Anal Quant Cytopathol Histpathol. 2012 Aug;34(4):189-94
Publication Type
Article
Date
Aug-2012
Author
Roland B Sennerstam
Hans Wiksell
Kai-Uwe Schässburger
Gert U Auer
Author Affiliation
Departments of Oncology and Pathology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden. roland.sennerstam@ki.se
Source
Anal Quant Cytopathol Histpathol. 2012 Aug;34(4):189-94
Date
Aug-2012
Language
English
Publication Type
Article
Keywords
Aged
Aged, 80 and over
Breast Neoplasms - epidemiology - pathology - radiography
Early Detection of Cancer
Female
Humans
Mammography
Middle Aged
Neoplasm Grading
Neoplasm Staging
Sweden - epidemiology
Treatment Outcome
Abstract
To study elderly women > or = 60 years of age diagnosed with breast cancer and analyze this cohort according to death from breast cancer and death due to comorbidities. Patients aged 60-69 years of age were included in routine mammography screening, but not women aged > or = 70 years. This enabled a comparison between the 2 groups regarding screening effect, tumor size and survival in breast cancer.
A consecutive sample of 311 breast cancer patients > or = 60 years of age from 1991 were analyzed according to tumor size at diagnosis, frequencies of lymph node metastasis, tumor histological grade and stage, ploidy, proliferation index, stem-line-scatter index and survival rate in breast cancer and other causes of death. Tumor size was compared to a patient group aged 60-69 from 1987, before the introduction of mammography screening in Sweden.
In the screening group a significant reduction in tumor size was found at diagnosis compared to the sample from 1987 (p or = 70 years (p
PubMed ID
23016465 View in PubMed
Less detail

Breast cancer and early retirement: Associations with disease characteristics, treatment, comorbidity, social position and participation in a six-day rehabilitation course in a register-based study in Denmark.

https://arctichealth.org/en/permalink/ahliterature137931
Source
Acta Oncol. 2011 Feb;50(2):274-81
Publication Type
Article
Date
Feb-2011
Author
Lars Henrik Damkjaer
Isabelle Deltour
Nis Palm Suppli
Jane Christensen
Niels T Kroman
Christoffer Johansen
Susanne Oksbjerg Dalton
Author Affiliation
Institute for Cancer Epidemiology, Copenhagen, Denmark. damkjaer@cancer.dk
Source
Acta Oncol. 2011 Feb;50(2):274-81
Date
Feb-2011
Language
English
Publication Type
Article
Keywords
Adult
Aged
Aged, 80 and over
Algorithms
Breast Neoplasms - epidemiology - pathology - rehabilitation - therapy
Comorbidity
Curriculum
Denmark - epidemiology
Disease Progression
Female
Follow-Up Studies
Humans
Middle Aged
Neoplasm Staging
Patient Education as Topic
Patient Participation
Registries
Retirement - statistics & numerical data
Social Class
Time Factors
Abstract
The purpose of this register-based study was to identify factors related to disease, treatment, sociodemographics and comorbidity associated with taking early retirement among women treated for breast cancer, and to evaluate the risk for taking early retirement among breast cancer survivors who attended a six-day rehabilitation course.
The study population consisted of 856 women who attended the rehabilitation course and a comparison group of 1 805 women who did not attend the course identified through the Danish Breast Cancer Cooperative Group. We obtained information on receipt of unemployment benefits, sickness benefits and early retirement pension for each of the years 1996-2007. Multivariate cox-regression models were used to analyze disease-specific, treatment-related, comorbidity and sociodemographics factors associated with early retirement after breast cancer and to evaluate the effect of attending a rehabilitation course on taking early retirement.
The rate of retirement was higher for women with somatic comorbidity (hazard ratio [HR], 1.91; 95% CI, 1.3; 2.9 for score 1, and HR 1.42; 95% CI, 0.7; 2.7 for score =2), previous depression (HR, 2.29; 95% CI, 1.7; 3.2) or having received sickness benefits in the year before their breast cancer diagnosis (HR, 3.75; 95% CI, 1.8; 7.8). Living with a partner was associated with a reduced hazard ratio for taking early retirement (HR, 0.70; 95% CI, 0.5-0.9). Having received chemotherapy, alone or in combination with anti-hormone treatment, reduced the hazard ratio (HR, 0.49; 95% CI, 0.3; 0.8 and HR, 0.5; 95% CI, 0.3; 0.8, respectively). The rate of retirement was higher for women the year after attending the rehabilitation course but returned to unity by three years.
The results of this study contribute to the identification of at-risk women and point to the need for tailored rehabilitation to avoid unnecessary marginalization of breast cancer survivors due to permanent labor market withdrawal.
PubMed ID
21231788 View in PubMed
Less detail

101 records – page 1 of 11.